Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteomics: recent applications and new technologies.

Mollisa M Elrick1, Jennie L Walgren, Michael D Mitchell

  • 1Worldwide Safety Sciences, Pfizer, Inc., 700 Chesterfield Parkway West, Chesterfield, MO 63017, USA.

Basic & Clinical Pharmacology & Toxicology
|April 26, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Will there ever be an in vitro assay that is predictive for human hepatotoxicity?

Archives of toxicology·2026
Same author

Update of the Methyltransferase Gene Family: Classification, Evolution and Biological Functions.

Human genomics·2026
Same author

Olive tree at the intersection of environment, public health, and One Health: a sustainable path to global wellbeing.

Frontiers in public health·2025
Same author

Synergistic toxicity in alcohol-associated liver disease and PFAS exposure.

Toxicological sciences : an official journal of the Society of Toxicology·2025
Same author

A Pharmacophore-Based Method for Rapid and Accurate Virtual Screening of Antibody Libraries against Antigens.

Molecular pharmaceutics·2025
Same author

Lessons learned from aldehyde dehydrogenases as non-P450 aldehyde-oxidizing enzymes: implications for the 'exposome' and human health.

Expert opinion on drug metabolism & toxicology·2025
Same journal

Using Pharmacovigilance Data for Signal Detection of Drug Interactions for Rosuvastatin.

Basic & clinical pharmacology & toxicology·2026
Same journal

Identifying Current Needs in Paediatric Pharmacoepidemiology: Insights From the NorPEN 2025 Workshop.

Basic & clinical pharmacology & toxicology·2026
Same journal

Contribution of Countries and International Collaboration in Clinical Pharmacology Research. A Cross-Sectional Bibliometric Study of Six Top Ranked Specialty Society Journals.

Basic & clinical pharmacology & toxicology·2026
Same journal

Pharmacological Inhibition of Cav2.2 Channels by Recombinant Phα1β Toxin (CTK01512-2).

Basic & clinical pharmacology & toxicology·2026
Same journal

Medication Burden: Beyond Counts to Recognize Polypharmacy as an Inherent Part of Living With Chronic Kidney Disease.

Basic & clinical pharmacology & toxicology·2026
Same journal

Modulation of Respiratory Diseases by the Endocannabinoid System: A Therapeutic Perspective.

Basic & clinical pharmacology & toxicology·2026
See all related articles

Proteomics is expanding for drug development and biomarker discovery. New tools and techniques, including microarrays, are improving proteomic analysis of complex samples like serum.

Area of Science:

  • Proteomics
  • Systems Biology
  • Biotechnology

Background:

  • Proteomics applications in drug development and research are rapidly growing.
  • Proteomic analyses are being applied to diverse biological samples and conditions.
  • Integrating proteomics with genomics and metabonomics in systems biology is a key trend.

Purpose of the Study:

  • To highlight the expanding applications of proteomics, particularly in drug development.
  • To discuss the challenges and opportunities in translating proteomic technologies to clinical settings.
  • To review advancements in proteomic tools and methodologies.

Main Methods:

  • Analysis of various biological samples including tissues and biofluids.
  • Development of enhanced bioinformatics tools and labeling procedures for 2D gel electrophoresis and protein quantification.

Related Experiment Videos

  • Utilizing activity-based probes for targeted protein enrichment.
  • Exploration of microarrays, including antibody-based and aptamer-based platforms.

    • Main Results:

    • Significant advancements in tools for proteomic analysis, including software and labeling techniques.
    • Emergence of activity-based probes for specific protein isolation.
    • Commercial availability of antibody-based microarrays and ongoing development of other microarray types.

    Conclusions:

    • The field of proteomics offers significant opportunities, especially in biomarker discovery for diseases and toxicology.
    • Overcoming the complexity of serum proteome analysis remains a key challenge, with new approaches emerging.
    • Continuous improvement in proteomic tools and technologies is crucial for advancing the field.